Analgesics in Sweden

Analgesics in Sweden

  • October 2016
  • 23 pages
  • Euromonitor International
Report ID: 149695
Sweden’s Medical Products Agency (MPA) announced in September 2014 its decision to ban sales of acetaminophen tablets and capsules in all retail outlets other than chemists/pharmacies. The reason for this was an observed correlation between increased acetaminophen usage and a rise in acetaminophen-related poisoning incidents. The ban took effect from 1 November 2015. Liquids, effervescent tablets and suppositories containing acetaminophen were not affected by the ban. The ban has, however, not h...

Euromonitor International’s Analgesics in Sweden report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

ANALGESICS IN SWEDEN
Euromonitor International
October 2016

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Analgesics by Category: Value 2011-2016
Table 2 Sales of Analgesics by Category: % Value Growth 2011-2016
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2011-2016
Table 4 NBO Company Shares of Analgesics: % Value 2012-2016
Table 5 LBN Brand Shares of Analgesics: % Value 2013-2016
Table 6 Forecast Sales of Analgesics by Category: Value 2016-2021
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2016-2021
Meda Ab in Consumer Health (sweden)
Strategic Direction
Key Facts
Summary 1 Meda AB: Key Facts
Summary 2 Meda AB: Operational Indicators
Competitive Positioning
Summary 3 Meda AB: Competitive Position 2016
Executive Summary
Further Positive Value Growth Registered in 2016
Rising Health Awareness Supports Growth
Fragmented Competitive Environment
Distribution Split Between A Number of Channels
Onwards and Upwards
Key Trends and Developments
Lifestyle Habits Give Rise To Obesity Concerns
Growing Demand for Snus
New Consumers Demanding More Sophisticated Products
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
Table 9 Life Expectancy at Birth 2011-2016
Market Data
Table 10 Sales of Consumer Health by Category: Value 2011-2016
Table 11 Sales of Consumer Health by Category: % Value Growth 2011-2016
Table 12 NBO Company Shares of Consumer Health: % Value 2012-2016
Table 13 LBN Brand Shares of Consumer Health: % Value 2013-2016
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2011-2016
Table 15 Distribution of Consumer Health by Format: % Value 2011-2016
Table 16 Distribution of Consumer Health by Format and Category: % Value 2016
Table 17 Forecast Sales of Consumer Health by Category: Value 2016-2021
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 4 OTC: Switches 2014-2016
Sources
Summary 5 Research Sources












Country=Sweden Industry=OTC ParentIndustry=Pharmaceutical Date=201610 Topic=MarketReport Publisher=EuromonitorInternational Price=1000